BioCryst to Report Third Quarter 2024 Financial Results on November 4
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) has announced that it will report its third quarter 2024 financial results on Monday, November 4, 2024. The company's management team will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the financial results and provide a corporate update.
Interested parties can access the live call by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. Additionally, a live webcast and replay of the call will be available in the investors section of the company's website at www.biocryst.com.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) ha annunciato che riporterà i suoi risultati finanziari del terzo trimestre 2024 lunedì, 4 novembre 2024. Il team di gestione dell'azienda terrà una conference call e webcast alle 8:30 a.m. ET lo stesso giorno per discutere i risultati finanziari e fornire un aggiornamento aziendale.
Le parti interessate possono accedere alla call in diretta componendo 1-844-481-2942 per i chiamanti nazionali e 1-412-317-1866 per i chiamanti internazionali. Inoltre, una diretta webcast e il replay della call saranno disponibili nella sezione investitori del sito web dell'azienda all'indirizzo www.biocryst.com.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) ha anunciado que presentará sus resultados financieros del tercer trimestre de 2024 el lunes 4 de noviembre de 2024. El equipo de gestión de la compañía llevará a cabo una conferencia telefónica y webcast a las 8:30 a.m. ET ese mismo día para discutir los resultados financieros y proporcionar una actualización corporativa.
Las partes interesadas pueden acceder a la llamada en vivo marcando 1-844-481-2942 para los llamantes domésticos y 1-412-317-1866 para los llamantes internacionales. Además, un webcast en vivo y la repetición de la llamada estarán disponibles en la sección de inversores del sitio web de la compañía en www.biocryst.com.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)는 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 발표일은 2024년 11월 4일 월요일입니다. 회사의 경영진 팀은 같은 날 오전 8시 30분 ET에 컨퍼런스 콜 및 웹캐스트를 진행하여 재무 결과를 논의하고 기업 업데이트를 제공할 예정입니다.
관심 있는 당사자는 국내 전화는 1-844-481-2942, 해외 전화는 1-412-317-1866로 전화를 걸어 라이브 콜에 접속할 수 있습니다. 또한 회사 웹사이트의 투자자 섹션에서 www.biocryst.com를 통해 라이브 웹캐스트 및 콜 재생이 제공됩니다.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le lundi 4 novembre 2024. L'équipe de direction de la société animera une conférence téléphonique et un webinaire à 8h30 ET le même jour pour discuter des résultats financiers et fournir une mise à jour de l'entreprise.
Les parties intéressées peuvent accéder à l'appel en direct en composant le 1-844-481-2942 pour les appelants nationaux et le 1-412-317-1866 pour les appelants internationaux. De plus, un webinaire en direct et un enregistrement de l'appel seront disponibles dans la section investisseurs du site Web de la société à l'adresse www.biocryst.com.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) hat bekannt gegeben, dass es seine Finanzergebnisse für das dritte Quartal 2024 am Montag, den 4. November 2024 veröffentlichen wird. Das Management-Team des Unternehmens wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und Webcast veranstalten, um die Finanzergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Interessierte Parteien können an dem Live-Call teilnehmen, indem sie 1-844-481-2942 für nationale Anrufer und 1-412-317-1866 für internationale Anrufer anrufen. Darüber hinaus stehen ein Live-Webcast und eine Wiederholung des Calls im Investorenbereich der Unternehmenswebsite unter www.biocryst.com zur Verfügung.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2024 financial results on Monday, November 4, 2024.
BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.
The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com
FAQ
When will BioCryst (BCRX) report its Q3 2024 financial results?
What time is BioCryst's (BCRX) Q3 2024 earnings call scheduled for?
How can investors access BioCryst's (BCRX) Q3 2024 earnings call?
Where can I find the replay of BioCryst's (BCRX) Q3 2024 earnings call?
